Document is current
Any future updates will be listed below
-
Authors
Bradley, Kameron
Moore, Camryn
Ishahak, Matthew
Maestas, Marlie M.
Veronese-Paniagua, Daniel A.
Millman, Jeffrey R.
-
Funding
Funding for this research was provided by:
Bill & Melinda Gates Foundation
NIH (T34GM083914)
NIH (T32DK007120)
NIH (T32GM139774)
NIH (R01DK114233)
Rita Levi-Montalcini Postdoctoral Fellowship in Regenerative Medicine
NSF (DGE-2139839)
Breakthrough T1D ((3-SRA-2023-1295-S-B)
Edward J. Mallinckrodt Foundation
Washington University School of Medicine Department of Medicine
Anita Palmer Corbin Trust
- License Information
-
More Information
Article History
Received: 22 July 2025
Accepted: 4 May 2026
First Online: 12 May 2026
Declarations
:
: J.R.M. is an inventor on related licensed patents and patent applications. D.A.V.P. and J.R.M. have stock in Sana Biotechnology. M.I. has stock in Vertex Pharmaceuticals. J.R.M. was previously employed by Sana Biotechnology. The remaining authors declare no competing interests.
